Cargando…
The Role of MicroRNAs in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers, leading to the second cancer-related death in the global. Although the treatment of HCC has greatly improved over the past few decades, the survival rate of patients is still quite low. Thus, it is urgent to explore new therapies, esp...
Autores principales: | Xu, Xin, Tao, Yuquan, Shan, Liang, Chen, Rui, Jiang, Hongyuan, Qian, Zijun, Cai, Feng, Ma, Lifang, Yu, Yongchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171016/ https://www.ncbi.nlm.nih.gov/pubmed/30310513 http://dx.doi.org/10.7150/jca.26350 |
Ejemplares similares
-
Huaier Augmented the Chemotherapeutic Sensitivity of Oxaliplatin via Downregulation of YAP in Hepatocellular Carcinoma
por: Tao, Yuquan, et al.
Publicado: (2018) -
Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1
por: Shan, Liang, et al.
Publicado: (2017) -
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinoma
por: Jiang, Hongyuan, et al.
Publicado: (2016) -
Exosomes in hepatocellular carcinoma: a new horizon
por: Chen, Rui, et al.
Publicado: (2019) -
Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma
por: Shan, Liang, et al.
Publicado: (2017)